| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 12 Feb 2026 | 6 Feb 2026 |
| Trident Texofab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 inter alia to consider and approve Un-Audited Fincnail Result for the Quarter ended 31.12.2025. The Board of Directors inter-alia has approved and taken on record Un-Audited Standalone Financial Results for the quarter and Nine months ended on December 31, 2025 along with Limited Review Report. (As Per BSE Announcement Dated on: 12/02/2026) | ||
| Board Meeting | 13 Nov 2025 | 5 Nov 2025 |
| Trident Texofab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 inter alia to consider and approve Un-Audited Financial result for Quarter and half year ended September 30 2025 The Board of Directors inter-alia has approved and taken on record Un-Audited Standalone Financial Results for the quarter and half year ended on September 30, 2025 along with Limited Review Report on said results issued by the Statutory Auditor of the Company. (As Per BSE Announcement Dated on: 13/11/2025) | ||
| Board Meeting | 26 Aug 2025 | 26 Aug 2025 |
| Outcome of Board Meeting held on August 26, 2025 Outcome of Board Meeting held on August 26, 2025 | ||
| Board Meeting | 13 Aug 2025 | 6 Aug 2025 |
| Trident Texofab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 inter alia to consider and approve un-audited standalone financial results of the Company for the quarter ended June 30 2025 The Board Meeting to be held on 12/08/2025 has been revised to 13/08/2025 The Board Meeting to be held on 12/08/2025 has been revised to 13/08/2025 (As per BSE Announcement Dated on 11/08/2025) Outcome of Board Meeting for Approval of Un-Audited Financial Results for the quarter ended on June 30, 2025 (As Per BSE Announcement Dated on: 13.08.2025) | ||
| Board Meeting | 4 Jun 2025 | 4 Jun 2025 |
| Conversion of 4,81,907 warrants into 4,81,907 equity shares of face value of Rs. 10/-each | ||
| Board Meeting | 29 May 2025 | 21 May 2025 |
| Trident Texofab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 inter alia to consider and approve the Audited financial result for Quarter and Year ended on 31.03.2025 Outcome of Board Meeting held on May 29, 2025 to consider and approve the financial result for the Quarter and year ended on March 31, 2025 (As per BSE Announcement Dated on 29/05/2025) | ||
| Board Meeting | 26 May 2025 | 26 May 2025 |
| Conversion of 96,287 warrants into 96,287 equity shares of face value of Rs. 10/- each. | ||
| Board Meeting | 12 May 2025 | 12 May 2025 |
| Conversion of 4,08,333 warrants into 4,08,333 equity shares of face value of Rs. 10/- each. | ||
| Board Meeting | 26 Mar 2025 | 26 Mar 2025 |
| Outcome of The Separate Meeting Of Independent Directors Of The Company Held On Wednesday, March 26, 2025. | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
